A. Hagey
Impact in
-
- Cancer Treatment and Pharmacology
-
- Synthesis and biological activity
- Synthesis and Biological Evaluation
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 11
- Colorectal Cancer Treatments and Studies 5
-
- Cancer therapeutics and mechanisms 7
- Co-authors
- Gary Gordon (10 shared papers)A. Coates (6 shared papers)Ezra E.W. Cohen (1 shared paper)Lee S. Schwartzberg (2 shared papers)C. Patrick (1 shared paper)Mark Kozloff (1 shared paper)Ann M. Mauer (2 shared papers)Jiang Qian (1 shared paper)
- Journals
- Journal of Clinical Oncology (11 papers)Blood (5 papers)Clinical Cancer Research (4 papers)Journal of Thoracic Oncology (2 papers)Chemotherapy (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
A. Hagey
26 papers receiving 475 citations
Peers
Comparison fields: 5 of 63
- Oncology 108
- Organic Chemistry 125
- Cell Biology 66
- Molecular Biology 205
- Cancer Research 33
Countries citing papers authored by A. Hagey
This map shows the geographic impact of A. Hagey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hagey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hagey more than expected).
Fields of papers citing papers by A. Hagey
This network shows the impact of papers produced by A. Hagey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hagey. The network helps show where A. Hagey may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Hagey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 78 | |
| 2 | 2006 | 71 | |
| 3 | 2005 | 64 | |
| 4 | 2006 | 54 | |
| 5 | 2012 | 46 | |
| 6 | 2008 | 41 | |
| 7 | 2010 | 36 | |
| 8 | 2007 | 18 | |
| 9 | 2011 | 12 | |
| 10 | 2004 | 7 | |
| 11 | 2011 | 6 | |
| 12 | 2005 | 6 | |
| 13 | 2010 | 5 | |
| 14 | 2005 | 5 | |
| 15 | 2005 | 5 | |
| 16 | 2005 | 5 | |
| 17 | 2006 | 4 | |
| 18 | 2005 | 4 | |
| 19 | 2004 | 4 | |
| 20 | In vitro cytotoxicity of ABT-751, a novel tubulin inhibitor, in pediatric solid tumor cell lines | 2006 | 2 |
About A. Hagey
A. Hagey is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Organic Chemistry and Neurology, having authored 26 papers that have together received 482 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Cancer therapeutics and mechanisms (7 papers), Lung Cancer Treatments and Mutations (6 papers), Neuroblastoma Research and Treatments (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Multiple Myeloma Research and Treatments (4 papers), Synthesis and pharmacology of benzodiazepine derivatives (3 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Oncology (108 citations), Organic Chemistry (125 citations), Cell Biology (66 citations), Molecular Biology (205 citations) and Cancer Research (33 citations). A. Hagey has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Gary Gordon, A. Coates, Ezra E.W. Cohen, Lee S. Schwartzberg, C. Patrick, Mark Kozloff, Ann M. Mauer, Jiang Qian, Frank M. Balis and Andrew Krivoshik. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, Journal of Thoracic Oncology and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.